People Briefs: New Executives At TearLab, SpectraScience And Pentax Medical
This article was originally published in The Gray Sheet
Executive Summary
TearLab Corp. names president and chief operating officer. SpectraScience appoints chief financial officer. New global president named at Pentax Medical. Meanwhile, DJO Global’s chief financial officer departs, and the former HHS National Coordinator for Health Information Technology has joined Brookings Institution.
You may also be interested in...
News Briefs: Device Tax Repeal Update; Surgery Firms Merge; Medtronic’s Drug-Eluting Balloon
House GOP freshman renew efforts to repeal the device tax. Minimally invasive surgery companies to merge. Medtronic submits the first module of the PMA for its drug-eluting balloon. More news.
News In Brief
Abbott, Dune Medical launch new products in U.S. Hologic, Covidien, DJO make acquisitions.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”